Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-?, and Glucose Transport in 3T3/L1 Adipocytes.

Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-?, and Glucose Transport in 3T3/L1 Adipocytes. Endocrinology. 2002 May 01; 143(5):1705-1716.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.